Literature DB >> 12829737

Disruption of lipid order by short-chain ceramides correlates with inhibition of phospholipase D and downstream signaling by FcepsilonRI.

Arun Gidwani1, H Alex Brown, David Holowka, Barbara Baird.   

Abstract

Specialized plasma membrane domains known as lipid rafts participate in signal transduction and other cellular processes, and their liquid-ordered properties appear to be important for their function. We investigated the possibility of using amphiphiles to disrupt lipid rafts and thereby inhibit IgE-FcepsilonRI signaling. We find that short-chain ceramides - C2-ceramide and C6-ceramide - decrease plasma membrane lipid order and reduce the extent of fluorescence resonance energy transfer between lipid-raft-associated molecules on intact cells; by contrast, biologically inactive C2-dihydroceramide does neither. Structural perturbations by these ceramides parallel their inhibitory effects on antigen-stimulated Ca2+ mobilization in RBL mast cells in the presence and absence of extracellular Ca2+. Similar inhibition of Ca2+ mobilization is caused by n-butanol, which prevents phosphatidic acid production by phospholipase D, but not by t-butanol, which does not prevent phosphatidic acid production. These results and previously reported effects of short-chain ceramides on phospholipase D activity prompted us to compare the effects of C2-ceramide, C2-dihydroceramide and C16-ceramide on phospholipase D1 and phospholipase D2 activities in vitro. We find that the effects of these ceramides on phospholipase D1 activity strongly correlate with their effects on antigen-stimulated Ca2+ mobilization and with their disruption of lipid order. Our results indicate that phospholipase D activity is upstream of antigen-stimulated Ca2+ mobilization in these cells, and they demonstrate that ceramides can serve as useful probes for investigating roles of plasma membrane structure and phospholipase D activity in cellular signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829737     DOI: 10.1242/jcs.00621

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  16 in total

Review 1.  Subcellular targeting strategies for drug design and delivery.

Authors:  Lawrence Rajendran; Hans-Joachim Knölker; Kai Simons
Journal:  Nat Rev Drug Discov       Date:  2010-01       Impact factor: 84.694

2.  Interaction between activated chemokine receptor 1 and FcepsilonRI at membrane rafts promotes communication and F-actin-rich cytoneme extensions between mast cells.

Authors:  Nimita H Fifadara; Freddy Beer; Shoichiro Ono; Santa J Ono
Journal:  Int Immunol       Date:  2010-02       Impact factor: 4.823

3.  Sphingosine derivatives inhibit cell signaling by electrostatically neutralizing polyphosphoinositides at the plasma membrane.

Authors:  Norah L Smith; Stephanie Hammond; Deepti Gadi; Alice Wagenknecht-Wiesner; Barbara Baird; David Holowka
Journal:  Self Nonself       Date:  2010

4.  Critical Casimir forces in cellular membranes.

Authors:  Benjamin B Machta; Sarah L Veatch; James P Sethna
Journal:  Phys Rev Lett       Date:  2012-09-24       Impact factor: 9.161

5.  Effect of ceramide N-acyl chain and polar headgroup structure on the properties of ordered lipid domains (lipid rafts).

Authors:  Peter Sawatzki; Thomas Kolter; Robert Bittman; Erwin London
Journal:  Biochim Biophys Acta       Date:  2007-05-13

6.  Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts.

Authors:  Gillian A Lang; Sergei D Maltsev; Gurdyal S Besra; Mark L Lang
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

7.  G-protein-coupled receptor-mediated traffic of Na,K-ATPase to the plasma membrane requires the binding of adaptor protein 1 to a Tyr-255-based sequence in the alpha-subunit.

Authors:  Riad Efendiev; Claudia E Budu; Alejandro M Bertorello; Carlos H Pedemonte
Journal:  J Biol Chem       Date:  2008-04-17       Impact factor: 5.157

8.  Phospholipase D modulation by ceramide in senescence.

Authors:  Lisa M Webb; Alan T Arnholt; Mark E Venable
Journal:  Mol Cell Biochem       Date:  2009-10-25       Impact factor: 3.396

9.  Nanoliposomal short-chain ceramide inhibits agonist-dependent translocation of neurotensin receptor 1 to structured membrane microdomains in breast cancer cells.

Authors:  Yasser Heakal; Mark Kester
Journal:  Mol Cancer Res       Date:  2009-05-12       Impact factor: 5.852

Review 10.  Sphingolipids in obesity, type 2 diabetes, and metabolic disease.

Authors:  S B Russo; J S Ross; L A Cowart
Journal:  Handb Exp Pharmacol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.